Managing drug-induced psychosis.
Baldaçara L, Ramos A, Castaldelli-Maia JM.
Int Rev Psychiatry. 2023 Aug-Sep;35(5-6):496-502. doi: 10.1080/09540261.2023.2261544. Epub 2024 Feb 1.
Psychotic disorders in DSM-5 and ICD-11.
Biedermann F, Fleischhacker WW.
CNS Spectr. 2016 Aug;21(4):349-54. doi: 10.1017/S1092852916000316. Epub 2016 Jul 15.
Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.
Endres D, Leypoldt F, Bechter K, Hasan A, Steiner J, Domschke K, Wandinger KP, Falkai P, Arolt V, Stich O, Rauer S, Prüss H, van Elst LT.
Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):803-818. doi: 10.1007/s00406-020-01113-2. Epub 2020 Mar 12.
Certain Aspects of Immunopychiatry.
Pandarakalam JP.
Psychiatr Danub. 2022 Winter;34(4):623-630. doi: 10.24869/psyd.2022.623.
[Acute and transient psychotic disorder at the onset of schizophrenia].
Le Galudec M, Sauder C, Stephan F, Robin G, Walter M.
Soins Psychiatr. 2014 Mar-Apr;(291):16-20.
Long-term clinical course of patients with acute polymorphic psychotic disorder without symptoms of schizophrenia.
Abe T, Otsuka K, Kato S.
Psychiatry Clin Neurosci. 2006 Aug;60(4):452-7. doi: 10.1111/j.1440-1819.2006.01531.x.
Epidemiology, course and outcome of acute polymorphic psychotic disorder: implications for ICD-11.
Castagnini A, Foldager L.
Psychopathology. 2014;47(3):202-6. doi: 10.1159/000357784. Epub 2014 Jan 28.
[Acute Psychotic Disorders].
Englisch S, Zink M.
Fortschr Neurol Psychiatr. 2020 Feb;88(2):121-138. doi: 10.1055/a-1008-7510. Epub 2020 Feb 26.
Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder.
Castagnini AC, Fusar-Poli P.
Eur Psychiatry. 2017 Sep;45:104-113. doi: 10.1016/j.eurpsy.2017.05.028. Epub 2017 Jun 2.
Cannabinoids and psychosis.
D'Souza DC.
Int Rev Neurobiol. 2007;78:289-326. doi: 10.1016/S0074-7742(06)78010-2.
